Lv1
100 积分 2022-05-13 加入
Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer: Analysis of the prospective multicenter SENTICOL cohort
6天前
已完结
PR066/#816 Efficacy of subsequent chemotherapy regimens in platinum-sensitive recurrent ovarian cancer following PARP inhibitor progression: a multicenter retrospective study
1个月前
已关闭
A mini-overview of antibody-drug conjugates in platinum-resistant ovarian cancer: A preclinical and clinical perspective
1个月前
已完结
CALLA trial: immunotherapy in locally advanced cervical cancer
1个月前
已完结
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
1个月前
已完结
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
1个月前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
1个月前
已完结
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics
2个月前
已完结
The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
2个月前
已完结
The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
2个月前
已完结
皖公网安备34019202002308
